Sticherling Christian, Kühne Michael, Schaer Beat, Altmann David, Osswald Stefan
University Hospital Basel, Division of Cardiology, Basel, Switzerland.
Swiss Med Wkly. 2009 Oct 17;139(41-42):596-601. doi: 10.4414/smw.2009.12667.
The number of patients implanted with cardiovascular electronic devices (CIED) like implantable defibrillators (ICD), cardiac resynchronisation (CRT) devices, and pacemakers continues to grow. These devices require regular follow-up interrogation in dedicated device clinics. Contemporary CIED are capable of wireless remote interrogation and monitoring. This technology has been proven to be technically reliable and helpful in certain conditions. It is of particular benefit in monitoring devices that are under a safety alert since it allows early identification of device malfunction and minimises the risk of under-reporting. There is also strong evidence that it helps to reduce heart failure hospitalisations in CRT and ICD patients. Furthermore, this technology proves to be very helpful in the early detection of arrhythmias like atrial fibrillation or ventricular tachyarrhythmias. Remote monitoring significantly reduces the number of follow-up visits, patients' and physicians' time spent per visit, and increases patients' adherence to follow-up visits. Future studies are needed to determine how to best allocate this new technology in a cost-effective manner.
植入诸如植入式除颤器（ICD）、心脏再同步化治疗（CRT）设备及起搏器等心血管电子设备（CIED）的患者数量持续增加。这些设备需要在专门的设备诊所进行定期随访问询。当代CIED具备无线远程问询和监测功能。这项技术已被证明在技术上是可靠的，并且在某些情况下很有帮助。在监测处于安全警报状态的设备时，它具有特别的优势，因为它能够早期识别设备故障，并将漏报风险降至最低。也有强有力的证据表明，它有助于减少CRT和ICD患者的心力衰竭住院次数。此外，这项技术在早期检测诸如房颤或室性快速心律失常等心律失常方面也非常有帮助。远程监测显著减少了随访次数、患者和医生每次随访所花费的时间，并提高了患者对随访的依从性。未来需要开展研究，以确定如何以具有成本效益的方式最佳地配置这项新技术。
